Peripheral Intravenous Catheters Market By Product Type (Short Peripheral Intravenous Catheters, Midline Peripheral Intravenous Catheters, Over-the-Needle Peripheral Intravenous Catheters), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Healthcare Providers), By Distribution Channel (Direct Sales, Distributors, Online Retailers), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Peripheral Intravenous Catheters Market was valued at USD 5.3 billion in 2024-e and will surpass USD 8.8 billion by 2030; growing at a CAGR of 8.6% during 2025 - 2030.

The peripheral intravenous catheters (PIVCs) market is experiencing steady growth due to their essential role in modern healthcare for the administration of fluids, medications, and blood products. These devices are commonly used in a variety of clinical settings, including hospitals, clinics, and ambulatory surgical centers. The demand for PIVCs is driven by the increasing need for intravenous therapies, especially in emergency and critical care settings. Technological advancements in catheter design, such as innovations in materials and insertion techniques, have further fueled the adoption of these devices.

In recent years, there has been a growing emphasis on improving the patient experience, such as reducing complications like infections and phlebitis. This shift has spurred the development of safer and more effective intravenous catheters, contributing to the market's growth. With an aging population, rising chronic diseases, and an increase in surgical procedures, the demand for PIVCs continues to rise. Furthermore, the increasing trend of home healthcare is expanding the market as more patients are treated outside traditional hospital settings, requiring high-quality PIVCs for safe intravenous therapy.

Short Peripheral Intravenous Catheters Segment is Largest Owing to High Usage in Routine Medical Care

The short peripheral intravenous catheters segment is the largest in the peripheral intravenous catheters market, owing to their widespread use in routine medical care. These catheters are typically inserted into the peripheral veins, providing quick and reliable access for short-term intravenous therapy. They are commonly used in hospitals, clinics, and ambulatory surgical centers for the administration of fluids, medications, and blood products.

Short peripheral intravenous catheters are easy to use, cost-effective, and offer minimal discomfort to patients, making them the preferred choice for a wide range of intravenous procedures. Additionally, their ability to be inserted quickly and their versatility in various clinical settings further contributes to their dominant position in the market. The segment is expected to continue growing due to the increasing number of outpatient procedures and the need for short-term intravenous access.

Midline Peripheral Intravenous Catheters Segment is Fastest Growing Owing to Longer Dwell Time and Reduced Complications

The midline peripheral intravenous catheters segment is the fastest growing in the market, driven by their longer dwell time and reduced risk of complications compared to short peripheral catheters. Midline catheters are designed for intermediate-term intravenous therapy and are typically inserted into veins of the upper arm. They are increasingly used in settings where patients require more extended intravenous treatments, such as those undergoing long-term medication or hydration therapy.

One of the key advantages of midline catheters is their ability to stay in place for several weeks without causing irritation or phlebitis, which are common complications of short peripheral catheters. This feature makes them particularly valuable for patients requiring frequent intravenous access, such as those with chronic conditions or undergoing chemotherapy. The growing demand for midline catheters is also supported by the rising trend of outpatient care, where extended intravenous therapy is often required.

Hospitals & Clinics Segment is Largest End-User Owing to High Patient Volume and Medical Infrastructure

Hospitals and clinics remain the largest end-user segment in the peripheral intravenous catheters market, driven by the high patient volume and advanced medical infrastructure available in these settings. These institutions are the primary locations for the administration of intravenous therapies, including hydration, medication, and blood transfusions.

In hospitals and clinics, PIVCs are used in a wide range of clinical procedures, from emergency care to routine treatments. The need for efficient intravenous access is critical in these environments, which has led to the widespread adoption of PIVCs. Furthermore, the continuous advancements in catheter technology, including innovations aimed at reducing complications, have increased the reliance on these devices in hospital and clinical settings. As the number of medical procedures and hospital admissions rises, so does the demand for peripheral intravenous catheters.

Direct Sales Segment is Largest Distribution Channel Owing to Greater Control Over Distribution and Relationships

The direct sales segment is the largest distribution channel in the peripheral intravenous catheters market, primarily due to the greater control it offers over distribution and the ability to foster stronger relationships with healthcare providers. Many manufacturers of PIVCs prefer to sell their products directly to hospitals, clinics, and other healthcare institutions to ensure that their products meet the required standards and to receive direct feedback from end-users.

Direct sales allow manufacturers to maintain a more personalized relationship with their customers and provide support for product training, ensuring that healthcare providers can efficiently use the devices. This channel also enables manufacturers to streamline their sales processes and maintain a consistent supply of products to hospitals and clinics, which is critical for ensuring the availability of PIVCs for patient care. As demand for these devices continues to rise, the direct sales segment is expected to remain the dominant distribution channel.

North America is Largest Region Owing to Advanced Healthcare Systems and High Demand for Intravenous Therapies

North America is the largest region in the peripheral intravenous catheters market, driven by the advanced healthcare systems in the United States and Canada, alongside the high demand for intravenous therapies. The presence of well-established healthcare infrastructure, advanced medical technologies, and a strong focus on patient care contribute to North America's dominance in the market.

Additionally, the aging population in North America, along with the increasing prevalence of chronic diseases and the growing number of surgical procedures, drives the demand for intravenous therapies. Hospitals and healthcare facilities in this region are highly reliant on high-quality intravenous catheters for patient care, further fueling market growth. Furthermore, the region's strong regulatory framework ensures that PIVCs meet high safety standards, which is a key factor driving their adoption in North America.

Competitive Landscape

The peripheral intravenous catheters market is competitive, with several key players leading the development and commercialization of innovative catheters. Companies are focused on improving the quality, safety, and ease of use of their products, aiming to reduce complications such as infections, phlebitis, and vein damage.

Market players are also expanding their product portfolios to include midline and over-the-needle catheters, responding to the growing demand for devices that offer longer dwell times and fewer complications. Strategic collaborations, mergers, and acquisitions are common in this market, as companies seek to expand their reach and enhance their technological capabilities. The growing trend of home healthcare and outpatient treatments is expected to present new opportunities for companies in the peripheral intravenous catheters market, particularly as more patients receive intravenous therapy at home.

List of Leading Companies:

• Becton, Dickinson and Company
• Medtronic
• Smiths Medical
• Terumo Corporation
• Fresenius Kabi
• Vygon
• B. Braun Melsungen AG
• Teleflex
• Johnson & Johnson
• Nipro Corporation
• ConvaTec Group
• AngioDynamics
• Baxter International
• ICU Medical
• Minerva Surgical

Recent Developments:

• In December 2024, Becton, Dickinson and Company launched a new IV catheter with an enhanced safety feature to reduce needlestick injuries.
• In November 2024, Medtronic introduced a new midline catheter designed for longer duration treatments with enhanced patient comfort.
• In October 2024, Smiths Medical announced the approval of a new over-the-needle IV catheter aimed at reducing complications during insertion.
• In September 2024, Terumo Corporation expanded its range of peripheral intravenous catheters for improved access in pediatric and geriatric patients.
• In August 2024, Fresenius Kabi introduced a new line of IV catheter kits that integrate advanced antiseptic technology for reduced infection rates.

Report Scope: